• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用蛋白质组学方法揭示白血病致癌 NUP98-HOXA9 和 SET-NUP214 融合蛋白的相互作用组。

Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.

机构信息

Institute of Molecular Biology and Medicine, Université Libre de Bruxelles, 6041 Charleroi, Belgium.

Present address: Institute of Biochemistry and Molecular Cell Biology, RWTH Aachen University, 52074 Aachen, Germany.

出版信息

Cells. 2020 Jul 10;9(7):1666. doi: 10.3390/cells9071666.

DOI:10.3390/cells9071666
PMID:32664447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7407662/
Abstract

The interaction of oncogenes with cellular proteins is a major determinant of cellular transformation. The NUP98-HOXA9 and SET-NUP214 chimeras result from recurrent chromosomal translocations in acute leukemia. Functionally, the two fusion proteins inhibit nuclear export and interact with epigenetic regulators. The full interactome of NUP98-HOXA9 and SET-NUP214 is currently unknown. We used proximity-dependent biotin identification (BioID) to study the landscape of the NUP98-HOXA9 and SET-NUP214 environments. Our results suggest that both fusion proteins interact with major regulators of RNA processing, with translation-associated proteins, and that both chimeras perturb the transcriptional program of the tumor suppressor p53. Other cellular processes appear to be distinctively affected by the particular fusion protein. NUP98-HOXA9 likely perturbs Wnt, MAPK, and estrogen receptor (ER) signaling pathways, as well as the cytoskeleton, the latter likely due to its interaction with the nuclear export receptor CRM1. Conversely, mitochondrial proteins and metabolic regulators are significantly overrepresented in the SET-NUP214 proximal interactome. Our study provides new clues on the mechanistic actions of nucleoporin fusion proteins and might be of particular relevance in the search for new druggable targets for the treatment of nucleoporin-related leukemia.

摘要

癌基因与细胞蛋白的相互作用是细胞转化的主要决定因素。NUP98-HOXA9 和 SET-NUP214 嵌合体是急性白血病中反复染色体易位的结果。从功能上讲,这两种融合蛋白抑制核输出并与表观遗传调节剂相互作用。NUP98-HOXA9 和 SET-NUP214 的全互作组目前尚不清楚。我们使用邻近依赖性生物素鉴定(BioID)来研究 NUP98-HOXA9 和 SET-NUP214 环境的全景。我们的结果表明,两种融合蛋白都与 RNA 加工的主要调节剂、与翻译相关的蛋白相互作用,并且两种嵌合体都扰乱了肿瘤抑制因子 p53 的转录程序。其他细胞过程似乎明显受到特定融合蛋白的影响。NUP98-HOXA9 可能扰乱 Wnt、MAPK 和雌激素受体 (ER) 信号通路,以及细胞骨架,后者可能是由于其与核输出受体 CRM1 的相互作用。相反,线粒体蛋白和代谢调节剂在 SET-NUP214 的近端互作组中显著过表达。我们的研究为核孔蛋白融合蛋白的作用机制提供了新的线索,并且在寻找核孔相关白血病的新治疗靶点方面可能具有特别重要的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/694df6612d4c/cells-09-01666-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/665d49ae5acc/cells-09-01666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/30f3d2ea82c5/cells-09-01666-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/5b8e610acd11/cells-09-01666-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/7ded27033524/cells-09-01666-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/9c195bad4f58/cells-09-01666-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/694df6612d4c/cells-09-01666-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/665d49ae5acc/cells-09-01666-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/30f3d2ea82c5/cells-09-01666-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/5b8e610acd11/cells-09-01666-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/7ded27033524/cells-09-01666-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/9c195bad4f58/cells-09-01666-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb3c/7407662/694df6612d4c/cells-09-01666-g006.jpg

相似文献

1
Disclosing the Interactome of Leukemogenic NUP98-HOXA9 and SET-NUP214 Fusion Proteins Using a Proteomic Approach.采用蛋白质组学方法揭示白血病致癌 NUP98-HOXA9 和 SET-NUP214 融合蛋白的相互作用组。
Cells. 2020 Jul 10;9(7):1666. doi: 10.3390/cells9071666.
2
Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.白血病致癌融合蛋白抑制转录因子的 CRM1 介导的核输出。
J Biol Chem. 2010 May 21;285(21):16248-57. doi: 10.1074/jbc.M109.048785. Epub 2010 Mar 16.
3
CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.CREB结合蛋白与核孔蛋白特异性FG重复序列相互作用,后者可激活转录并介导NUP98-HOXA9致癌性。
Mol Cell Biol. 1999 Jan;19(1):764-76. doi: 10.1128/MCB.19.1.764.
4
Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes.与染色质预结合的Crm1招募Nup98-HoxA9融合蛋白以诱导Hox基因簇的异常表达。
Elife. 2016 Jan 7;5:e09540. doi: 10.7554/eLife.09540.
5
Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.NUP98-HOXA9 癌蛋白与氨基末端分裂增强子(AES)相互作用,增强其转化能力。
J Biol Chem. 2011 Nov 11;286(45):38989-9001. doi: 10.1074/jbc.M111.297952. Epub 2011 Sep 21.
6
Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins.动力蛋白轻链1(DYNLT1)与正常和致癌核孔蛋白相互作用。
PLoS One. 2013 Jun 26;8(6):e67032. doi: 10.1371/journal.pone.0067032. Print 2013.
7
The SQSTM1-NUP214 fusion protein interacts with Crm1, activates Hoxa and Meis1 genes, and drives leukemogenesis in mice.SQSTM1-NUP214 融合蛋白与 Crm1 相互作用,激活 Hoxa 和 Meis1 基因,并在小鼠中驱动白血病发生。
PLoS One. 2020 Apr 28;15(4):e0232036. doi: 10.1371/journal.pone.0232036. eCollection 2020.
8
NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.携带NUP98-HOXA9的治疗相关髓系肿瘤涉及髓系定向细胞,并诱导HOXA5、EVI1、FLT3和MEIS1表达。
Int J Lab Hematol. 2016 Feb;38(1):64-71. doi: 10.1111/ijlh.12435. Epub 2015 Sep 29.
9
Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure.核孔融合蛋白形成的液-液相分离核体促进了 MLL1/CRM1 的凝聚和 3D 基因组结构的重排。
Cell Rep. 2023 Aug 29;42(8):112884. doi: 10.1016/j.celrep.2023.112884. Epub 2023 Jul 29.
10
The Retinoblastoma Tumor Suppressor Is Required for the NUP98-HOXA9-Induced Aberrant Nuclear Envelope Phenotype.视网膜母细胞瘤肿瘤抑制因子是 NUP98-HOXA9 诱导的异常核膜表型所必需的。
Cells. 2021 Oct 22;10(11):2851. doi: 10.3390/cells10112851.

引用本文的文献

1
An Overview of 10 Anniversary of -Advances in Cell Nuclei: Function, Transport and Receptors.细胞核:功能、运输和受体的进展十周年综述。
Cells. 2022 Dec 23;12(1):55. doi: 10.3390/cells12010055.
2
Modulating biomolecular condensates: a novel approach to drug discovery.调控生物分子凝聚物:一种新的药物发现方法。
Nat Rev Drug Discov. 2022 Nov;21(11):841-862. doi: 10.1038/s41573-022-00505-4. Epub 2022 Aug 16.
3
Misregulation of Nucleoporins 98 and 96 leads to defects in protein synthesis that promote hallmarks of tumorigenesis.

本文引用的文献

1
Targeted CRM1-inhibition perturbs leukemogenic NUP214 fusion proteins and exerts anti-cancer effects in leukemia cell lines with rearrangements.靶向CRM1抑制可扰乱致白血病的NUP214融合蛋白,并对具有重排的白血病细胞系发挥抗癌作用。
Oncotarget. 2020 Sep 8;11(36):3371-3386. doi: 10.18632/oncotarget.27711.
2
Local Translation in Axons: When Membraneless RNP Granules Meet Membrane-Bound Organelles.轴突中的局部翻译:当无膜核糖核蛋白颗粒与膜结合细胞器相遇时。
Front Mol Biosci. 2019 Nov 22;6:129. doi: 10.3389/fmolb.2019.00129. eCollection 2019.
3
Chromatin-bound CRM1 recruits SET-Nup214 and NPM1c onto clusters causing aberrant expression in leukemia cells.
核孔蛋白 98 和 96 的失调导致蛋白质合成缺陷,从而促进肿瘤发生的标志性特征。
Dis Model Mech. 2022 Mar 1;15(3). doi: 10.1242/dmm.049234. Epub 2022 Mar 16.
4
New Activities of the Nuclear Pore Complexes.核孔复合体的新活动。
Cells. 2021 Aug 18;10(8):2123. doi: 10.3390/cells10082123.
5
A genetic screen in Drosophila uncovers the multifaceted properties of the NUP98-HOXA9 oncogene.果蝇中的遗传筛选揭示了 NUP98-HOXA9 癌基因的多方面特性。
PLoS Genet. 2021 Aug 12;17(8):e1009730. doi: 10.1371/journal.pgen.1009730. eCollection 2021 Aug.
6
CircRNA FUT10 regulates the regenerative potential of aged skeletal muscle stem cells by targeting HOXA9.环状RNA FUT10通过靶向HOXA9调节衰老骨骼肌干细胞的再生潜能。
Aging (Albany NY). 2021 Jul 13;13(13):17428-17441. doi: 10.18632/aging.203233.
染色质结合的 CRM1 将 SET-Nup214 和 NPM1c 募集到 斑点上,导致白血病细胞中的异常表达。
Elife. 2019 Nov 22;8:e46667. doi: 10.7554/eLife.46667.
4
Structural prerequisites for CRM1-dependent nuclear export signaling peptides: accessibility, adapting conformation, and the stability at the binding site.CRM1 依赖性核输出信号肽的结构前提条件:可及性、适应构象和结合位点的稳定性。
Sci Rep. 2019 Apr 29;9(1):6627. doi: 10.1038/s41598-019-43004-0.
5
Tubulin is actively exported from the nucleus through the Exportin1/CRM1 pathway.微管蛋白通过 Exportin1/CRM1 途径从细胞核主动输出。
Sci Rep. 2019 Apr 5;9(1):5725. doi: 10.1038/s41598-019-42056-6.
6
Automated exploration of gene ontology term and pathway networks with ClueGO-REST.使用 ClueGO-REST 自动探索基因本体论术语和途径网络。
Bioinformatics. 2019 Oct 1;35(19):3864-3866. doi: 10.1093/bioinformatics/btz163.
7
Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0).PANTHER 分类系统(版本 14.0)进行大规模基因组和基因功能分析的方案更新。
Nat Protoc. 2019 Mar;14(3):703-721. doi: 10.1038/s41596-019-0128-8. Epub 2019 Feb 25.
8
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy.mTOR 信号通路与 mTOR 抑制剂在实体肿瘤靶向治疗中的应用。
Int J Mol Sci. 2019 Feb 11;20(3):755. doi: 10.3390/ijms20030755.
9
NUP214 in Leukemia: It's More than Transport.NUP214 在白血病中的作用:不止是运输。
Cells. 2019 Jan 21;8(1):76. doi: 10.3390/cells8010076.
10
PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools.PANTHER 版本 14:更多基因组、一个新的 PANTHER GO-slim 和富集分析工具的改进。
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426. doi: 10.1093/nar/gky1038.